PAH Associated With Systemic Lupus Erythematosus

PAH Associated With Systemic Lupus Erythematosus

Patients with SLE-PAH have an overall 5-year survival rate of 83.9% after the Pulmonary Arterial Hypertension (PAH) diagnosis. Anti-SSA/SSB antibodies may be a risk factor for PAH, and the presence of anti-U1-RNP antibodies... read more

Attenuated T-cell Vaccination Helps SLE Patients

Attenuated T-cell Vaccination Helps SLE Patients

Vaccinating systemic lupus erythematosus (SLE) patients with attenuated T-cells improved their symptoms, according to results of a small controlled trial. T-cells are immune cells that play a key role in lupus.... read more